查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572073

人工肺市場：按產品類型、技術、患者年齡層、組件、應用和最終用戶 - 2025-2030 年全球預測

Artificial Lung Market by Product Type (Extracorporeal Membrane Oxygenation, Intrapulmonary Gas Exchange, Paracorporeal Artificial Lungs), Technology, Patient Age Group, Component, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人工肺市場價值為70.2億美元，預計到2024年將達到76.3億美元，複合年成長率為8.76%，到2030年將達到126.5億美元。

氧合器市場包括複製或支援活體肺部氣體交換能力的設備和技術，主要用於管理呼吸衰竭和疾病。隨著慢性呼吸道疾病在全球的流行，對氧合器系統的需求變得越來越重要。應用範圍從加護病房的臨時呼吸支持到肺可用性有限的移植情況下的替代。汽車、醫學研究和醫療保健產業作為最終用途領域，材料和生物相容性技術的進步也越來越引起生物技術公司的興趣。慢性阻塞性肺病（COPD）和急性呼吸窘迫症候群（ARDS）發生率的上升以及全球人口老化是市場促進因素。隨著攜帶式和植入式氧合器的發展，生物材料的創新可以延長設備的使用壽命，從而提供了利潤豐厚的機會。然而，高製造成本、嚴格的監管要求和潛在的生物相容性問題等挑戰可能會阻礙市場成長。為了利用商機，公司應透過奈米技術和生物相容性聚合物的研究，重點在於提高設備的效率和人體工學。探索將機械支撐和生物組織工程結合的混合系統也具有潛力。市場的本質是競爭性的，創新的時機已經成熟，主要參與者投資於研發以克服挑戰和監管障礙。作為分析師，我建議投資與醫學研究機構的合作，並探索官民合作關係，以促進創新並提高監管合規性。向監管寬鬆的新興市場擴張可以放寬准入門檻並提高市場滲透率。日益開拓以患者為中心的方法（例如開發個人化氧合器解決方案）也有可能加速採用、改善患者治療結果並推動市場擴張。

主要市場統計
基準年[2023] 70.2億美元
預測年份 [2024] 76.3億美元
預測年份 [2030] 126.5億美元
複合年成長率（%） 8.76%

市場動態：揭示快速發展的人工肺市場的關鍵市場洞察

供需的動態交互作用正在改變制氧機市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 呼吸系統疾病和肺移植的增加推動了對人工肺的需求
    • 充氧器設計和功能的技術進步推動產業成長
    • 增加充氧器系統研發的投資和經費
    • 老年人口的增加和慢性肺部疾病發生率的增加將推動市場需求
  • 市場限制因素
    • 操作和維護充氧器設備所需的熟練專業人員和專業知識有限；
    • 對充氧器材料的生物相容性和長期耐用性的擔憂會影響採用率
  • 市場機會
    • 開發人工智慧驅動的氧合器以最佳化呼吸支援系統
    • 再生醫學方法創造長壽且耐用的人工肺
    • 制氧機與物聯網整合，實現即時監控與維護
  • 市場挑戰
    • 技術限制和可靠性問題阻礙了氧合器在醫療機構中的廣泛使用
    • 影響人工肺部研究、開發和部署的倫理考量和社會認知問題

波特五力：駕馭制氧機市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對氧合器市場的影響

外部宏觀環境因素對人工肺市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解制氧機市場的競爭狀況

對人工肺市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣氧合器市場供應商績效評估

FPNV定位矩陣是評估制氧機市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了人工肺市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，人工肺市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 呼吸系統疾病和肺移植的增加增加了對人工肺的需求
      • 充氧器設計和功能的技術進步推動產業成長
      • 增加充氧器系統研發的投資和經費
      • 老年人口的成長和慢性肺部疾病發病率的上升正在推動市場需求。
    • 抑制因素
      • 操作和維護氧合器設備所需的熟練專業人員和專業知識有限
      • 對充氧器材料的生物相容性和長期耐用性的擔憂會影響採用率
    • 機會
      • 開發人工智慧驅動的人工肺以最佳化呼吸支援系統
      • 再生醫學方法創造持久耐用的人工肺
      • 制氧機與物聯網 (IoT) 整合，實現即時監控和維護
    • 任務
      • 技術限制和可靠性問題減緩了醫療機構中氧合器的使用
      • 影響人工肺部研究、開發和實施的倫理考量和輿論問題
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人工肺市場：依產品類型

  • 體外膜氧合（ECMO）
  • 肺內氣體交換
  • 體外氧合器

第7章人工肺市場：依技術分類

  • 儲氧技術
  • 泵浦技術
  • 感測器和監視器

第8章依患者年齡層分類的人工肺市場

  • 成人用
  • 老年病
  • 新生
  • 小兒科

第9章人工肺市場：依組成部分

  • 插管
  • 控制器
  • 膜式充氧器
  • 泵浦

第10章人工肺市場：依應用分類

  • 急性呼吸窘迫症候群（ARDS）
  • 心肺體外迴圈
  • 慢性阻塞性肺病（COPD）

第11章人工肺市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章美洲人工肺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太人工肺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲人工肺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0598

The Artificial Lung Market was valued at USD 7.02 billion in 2023, expected to reach USD 7.63 billion in 2024, and is projected to grow at a CAGR of 8.76%, to USD 12.65 billion by 2030.

The artificial lung market encompasses devices and technologies that replicate or support the gas exchange functions of biological lungs, primarily to manage respiratory failures or diseases. With a growing prevalence of chronic respiratory diseases worldwide, the demand for artificial lung systems is becoming increasingly vital. Applications span from temporary respiratory support in intensive care units to alternatives in transplant scenarios, where lung availability is limited. Automotive, medical research, and healthcare sectors serve as end-use domains, with an increasing interest from biotechnology firms due to advancements in materials and biocompatible technologies. A significant growth driver is the rise in chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) cases, as well as the global aging population, which boosts market potential. Innovations in biomaterials leading to improved device lifespan, alongside the development of portable and implantable artificial lungs, offer lucrative opportunities. However, challenges like high manufacturing costs, stringent regulatory requirements, and potential biocompatibility issues may impede market growth. To capitalize on opportunities, companies should focus on enhancing device efficiency and ergonomics through research into nanotechnology and biocompatible polymers. There is also potential in exploring hybrid systems that combine mechanical support with biological tissue engineering. The nature of the market is both competitive and ripe for innovation, dominated by key players investing in R&D to outpace challenges and regulatory hurdles. As an analyst, I recommend investing in collaborations with medical research institutions and exploring public-private partnerships to foster innovation and facilitate regulatory compliance. Expanding into emerging markets, which may have less stringent regulations, could offer easier entry points and further market penetration. Enhanced focus on patient-centric approaches, such as developing personalized artificial lung solutions, could also bolster adoption and improve patient outcomes, driving market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 7.02 billion
Estimated Year [2024] USD 7.63 billion
Forecast Year [2030] USD 12.65 billion
CAGR (%) 8.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Lung Market

The Artificial Lung Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
    • Technological advancements in artificial lung design and functionality driving industry growth
    • Growing investment and funding in research and development of artificial lung systems
    • Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
  • Market Restraints
    • Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
    • Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
  • Market Opportunities
    • Development of ai-driven artificial lungs to optimize respiratory support systems
    • Regenerative medicine approaches for creating long-lasting and durable artificial lungs
    • Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
  • Market Challenges
    • Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
    • Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Lung Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Lung Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Lung Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Lung Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Lung Market

A detailed market share analysis in the Artificial Lung Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Lung Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Lung Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Lung Market

A strategic analysis of the Artificial Lung Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Lung Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALung Technologies, Inc., B. Braun Melsungen AG, Baxter International Inc., Breethe, Inc., CardiacAssist, Inc., Cleveland Clinic, Dragerwerk AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, Maquet Holding B.V. & Co. KG, McGowan Institute for Regenerative Medicine, Medtronic plc, Novalung GmbH, Organ Care System (OCS), Respiratory Assist, Terumo Corporation, Xenios AG, and Xenios USA, Inc.

Market Segmentation & Coverage

This research report categorizes the Artificial Lung Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Extracorporeal Membrane Oxygenation (ECMO), Intrapulmonary Gas Exchange, and Paracorporeal Artificial Lungs.
  • Based on Technology, market is studied across Oxygenator Technology, Pump Technology, and Sensors and Monitors.
  • Based on Patient Age Group, market is studied across Adult, Geriatric, Neonates, and Pediatric.
  • Based on Component, market is studied across Cannulas, Controllers, Membrane Oxygenators, and Pumps.
  • Based on Application, market is studied across Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass, and Chronic Obstructive Pulmonary Disease (COPD).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
      • 5.1.1.2. Technological advancements in artificial lung design and functionality driving industry growth
      • 5.1.1.3. Growing investment and funding in research and development of artificial lung systems
      • 5.1.1.4. Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
      • 5.1.2.2. Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of ai-driven artificial lungs to optimize respiratory support systems
      • 5.1.3.2. Regenerative medicine approaches for creating long-lasting and durable artificial lungs
      • 5.1.3.3. Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
    • 5.1.4. Challenges
      • 5.1.4.1. Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
      • 5.1.4.2. Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Lung Market, by Product Type

  • 6.1. Introduction
  • 6.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 6.3. Intrapulmonary Gas Exchange
  • 6.4. Paracorporeal Artificial Lungs

7. Artificial Lung Market, by Technology

  • 7.1. Introduction
  • 7.2. Oxygenator Technology
  • 7.3. Pump Technology
  • 7.4. Sensors and Monitors

8. Artificial Lung Market, by Patient Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Neonates
  • 8.5. Pediatric

9. Artificial Lung Market, by Component

  • 9.1. Introduction
  • 9.2. Cannulas
  • 9.3. Controllers
  • 9.4. Membrane Oxygenators
  • 9.5. Pumps

10. Artificial Lung Market, by Application

  • 10.1. Introduction
  • 10.2. Acute Respiratory Distress Syndrome (ARDS)
  • 10.3. Cardiopulmonary Bypass
  • 10.4. Chronic Obstructive Pulmonary Disease (COPD)

11. Artificial Lung Market, by End-User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Americas Artificial Lung Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Artificial Lung Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Artificial Lung Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ALung Technologies, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Breethe, Inc.
  • 6. CardiacAssist, Inc.
  • 7. Cleveland Clinic
  • 8. Dragerwerk AG & Co. KGaA
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. Getinge AB
  • 11. Hemovent GmbH
  • 12. Maquet Holding B.V. & Co. KG
  • 13. McGowan Institute for Regenerative Medicine
  • 14. Medtronic plc
  • 15. Novalung GmbH
  • 16. Organ Care System (OCS)
  • 17. Respiratory Assist
  • 18. Terumo Corporation
  • 19. Xenios AG
  • 20. Xenios USA, Inc

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL LUNG MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL LUNG MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL LUNG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL LUNG MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY INTRAPULMONARY GAS EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PARACORPOREAL ARTIFICIAL LUNGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY OXYGENATOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY SENSORS AND MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023